AnaptysBio Inc
ANAB
$47.66-2.16%
Delayed · as of Oct 16, 2026, 11:46 AM ET
Mkt cap
$1.62B
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-03-31)
$25.56M
EPS (9mo ended 2025-09-30)
$-2.16
Gross Margin (qtr ended 2026-03-31)
N/A
Profit Margin (qtr ended 2026-03-31)
-206.93%
Beta
N/A
Div yield
N/A
Sector
Healthcare
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Latest reported ANAB revenue for 2026-03-31 was $25.6M. Net income was -$52.9M. Revenue was down 66.5% from 2025-09-30 to 2026-03-31. ANAB currently screens at market cap $1.62B.
Use this ANAB research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ANAB income, balance, and cash tables.
AnaptysBio Inc (ANAB) is a biotechnology company in the Healthcare sector.
Latest cached AnaptysBio Inc (ANAB) revenue for Mar 31, 2026 was $25.6M. Net income was -$52.9M. Statements: https://lician.com/financials/anab
AnaptysBio Inc (ANAB) market capitalization is $1.62B on the latest cached snapshot.
AnaptysBio Inc (ANAB) cached previous close $48.71; day range $47.66 – $48.56; volume 86,653. Session quote: https://lician.com/quote/anab
AnaptysBio Inc (ANAB) latest cached earnings event is "ANAB earnings" on Sep 9, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ANAB filing is 8-K · Sep 21, 2026. Filings: https://lician.com/sec/anab